Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MERTK anticorps (Extracellular) (FITC)

L’anticorps Lapin Polyclonal anti-MERTK a été validé pour FACS et LCI. Il convient pour détecter MERTK dans des échantillons de Souris.
N° du produit ABIN7237599

Aperçu rapide pour MERTK anticorps (Extracellular) (FITC) (ABIN7237599)

Antigène

Voir toutes MERTK Anticorps
MERTK (C-Mer Proto-Oncogene Tyrosine Kinase (MERTK))

Reactivité

  • 85
  • 38
  • 27
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Souris

Hôte

  • 69
  • 21
  • 2
  • 2
  • 1
Lapin

Clonalité

  • 60
  • 35
Polyclonal

Conjugué

  • 58
  • 9
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp MERTK est conjugé à/à la FITC

Application

  • 54
  • 48
  • 46
  • 14
  • 14
  • 12
  • 11
  • 9
  • 9
  • 8
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Live Cell Imaging (LCI)
  • Épitope

    • 13
    • 12
    • 8
    • 8
    • 7
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 402-416, Extracellular

    Fonction

    A Rabbit Polyclonal Antibody to MERTK (extracellular) conjugated to the fluorescent dye FITC

    Specificité

    Extracellular, N-terminus.

     Réactivité croisée

    Humain, Souris, Rat

    Homologie

    Rat - identical, human - 13,15 amino acid residues identical

    Attributs du produit

    Extracellular, N-terminus

    Purification

    Affinity purified on immobilized antigen.

    Immunogène

    Immunogen: Synthetic peptide

    Immunogen Sequence: (C)KPPIKRQDGELVGYR, corresponding to amino acid residues 402 - 416 of mouse MERTK

    Isotype

    IgG
  • Indications d'application

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: N/A

    Application Dilutions Western blot wb: N/A

    Commentaires

    Negative Control: (ABIN7582044)

    Blocking Peptide: (ABIN7234888)

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Recosntitute with double distilled water (DDW) to a concentration of 1.0 mg/mL.

    Concentration

    1 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C, protected from the light, for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Antigène

    MERTK (C-Mer Proto-Oncogene Tyrosine Kinase (MERTK))

    Autre désignation

    MERTK

    Sujet

    Receptor tyrosine kinase MerTK, C-Mer Proto-Oncogene Tyrosine Kinase, Mer, Proto-Oncogene C-Mer,Myeloid-epithelial-reproductive tyrosine kinase, MERTK, is a receptor tyrosine kinase of the TAM (Tyro3, Axl and MERTK) family, expressed in numerous cancers1.The extracellular N-terminal domain contains two immunoglobulin-like and two fibronectin 3 domains, followed by a hydrophobic single pass transmembrane domain, and a cytoplasmic C-terminal tail containing a tyrosine kinase domain1,2.Auto-phosphorylation induced by ligand binding influences a range of downstream signaling pathways and cellular functions2. The physiological roles of MERTK include regulation of tissue homeostasis and repair, innate immune control, and platelet aggregation. However, aberrant expression of this protein promotes neoplasia, cell cycle progression, proliferation and tumor growth, resistance to apoptosis, and promotion of tumor metastases.MERTK is involved in the activation of several canonic oncogenic signaling pathways in various types of cancers including: leukemia, non-small cell lung cancer, glioblastoma, melanoma, prostate cancer, breast cancer, colon cancer and gastric cancer1,3,4.Due to its pivotal role in cancer development and metastasis, multiple therapeutic approaches are currently in development to inhibit MERTK, including ligand "traps" and small-molecule tyrosine kinase inhibitors4.

    Alternative names: Receptor tyrosine kinase MerTK, C-Mer Proto-Oncogene Tyrosine Kinase, Mer, Proto-Oncogene C-Mer

    ID gène

    17289

    NCBI Accession

    NM_006343

    UniProt

    Q60805

    Pathways

    Signalisation RTK
Vous êtes ici:
Chat with us!